Comfortis

RSS

Withdrawn

This medicine's authorisation has been withdrawn

spinosad
MedicineVeterinaryWithdrawn

Dutch is available via eTranslation, the European Commission's machine translation service.

Translate to Dutch | Important information about machine translation

  • Application under evaluation
  • CVMP opinion
  • European Commission decision

Overview

The marketing authorisation for Comfortis has been withdrawn at the request of the marketing authorisation holder

български (BG) (236.57 kB - PDF)

Bekijk

español (ES) (187.74 kB - PDF)

Bekijk

čeština (CS) (226.05 kB - PDF)

Bekijk

dansk (DA) (161.59 kB - PDF)

Bekijk

Deutsch (DE) (171.6 kB - PDF)

Bekijk

eesti (ET) (155.77 kB - PDF)

Bekijk

ελληνικά (EL) (264.18 kB - PDF)

Bekijk

français (FR) (189.24 kB - PDF)

Bekijk

hrvatski (HR) (198.87 kB - PDF)

Bekijk

italiano (IT) (161.61 kB - PDF)

Bekijk

latviešu (LV) (225.08 kB - PDF)

Bekijk

lietuvių (LT) (224.56 kB - PDF)

Bekijk

magyar (HU) (217.9 kB - PDF)

Bekijk

Malti (MT) (216.58 kB - PDF)

Bekijk

Nederlands (NL) (191.07 kB - PDF)

Bekijk

polski (PL) (205.46 kB - PDF)

Bekijk

português (PT) (165.42 kB - PDF)

Bekijk

română (RO) (234.04 kB - PDF)

Bekijk

slovenčina (SK) (203.46 kB - PDF)

Bekijk

slovenščina (SL) (219.22 kB - PDF)

Bekijk

suomi (FI) (179.48 kB - PDF)

Bekijk

svenska (SV) (185.78 kB - PDF)

Bekijk

Product information

български (BG) (1 MB - PDF)

Bekijk

español (ES) (788.73 kB - PDF)

Bekijk

čeština (CS) (931.05 kB - PDF)

Bekijk

dansk (DA) (761.7 kB - PDF)

Bekijk

Deutsch (DE) (837.99 kB - PDF)

Bekijk

eesti (ET) (986.97 kB - PDF)

Bekijk

ελληνικά (EL) (1.1 MB - PDF)

Bekijk

français (FR) (813.94 kB - PDF)

Bekijk

hrvatski (HR) (961.72 kB - PDF)

Bekijk

italiano (IT) (835.06 kB - PDF)

Bekijk

latviešu (LV) (1.1 MB - PDF)

Bekijk

lietuvių (LT) (1.05 MB - PDF)

Bekijk

magyar (HU) (924.98 kB - PDF)

Bekijk

Malti (MT) (1.01 MB - PDF)

Bekijk

Nederlands (NL) (803.63 kB - PDF)

Bekijk

polski (PL) (993.24 kB - PDF)

Bekijk

português (PT) (802.47 kB - PDF)

Bekijk

română (RO) (969.27 kB - PDF)

Bekijk

slovenčina (SK) (943.68 kB - PDF)

Bekijk

slovenščina (SL) (925.44 kB - PDF)

Bekijk

suomi (FI) (789.17 kB - PDF)

Bekijk

svenska (SV) (753.4 kB - PDF)

Bekijk

Íslenska (IS) (733.62 kB - PDF)

Bekijk

norsk (NO) (762.11 kB - PDF)

Bekijk
Latest procedure affecting product information:IB/0025/G
10/09/2021

български (BG) (351.84 kB - PDF)

Bekijk

español (ES) (294.94 kB - PDF)

Bekijk

čeština (CS) (261.47 kB - PDF)

Bekijk

dansk (DA) (280.02 kB - PDF)

Bekijk

Deutsch (DE) (288.43 kB - PDF)

Bekijk

eesti (ET) (287.9 kB - PDF)

Bekijk

ελληνικά (EL) (326.3 kB - PDF)

Bekijk

français (FR) (295.94 kB - PDF)

Bekijk

hrvatski (HR) (329.99 kB - PDF)

Bekijk

italiano (IT) (291.52 kB - PDF)

Bekijk

latviešu (LV) (321.16 kB - PDF)

Bekijk

lietuvių (LT) (267.62 kB - PDF)

Bekijk

magyar (HU) (305.68 kB - PDF)

Bekijk

Malti (MT) (310.01 kB - PDF)

Bekijk

Nederlands (NL) (288.83 kB - PDF)

Bekijk

polski (PL) (310.43 kB - PDF)

Bekijk

português (PT) (284.42 kB - PDF)

Bekijk

română (RO) (294.1 kB - PDF)

Bekijk

slovenčina (SK) (310.17 kB - PDF)

Bekijk

slovenščina (SL) (345.29 kB - PDF)

Bekijk

suomi (FI) (287.08 kB - PDF)

Bekijk

svenska (SV) (286.33 kB - PDF)

Bekijk

Íslenska (IS) (296.28 kB - PDF)

Bekijk

norsk (NO) (282.34 kB - PDF)

Bekijk

Product details

Name of medicine
Comfortis
Active substance
spinosad
International non-proprietary name (INN) or common name
spinosad
Species
  • Dogs
  • Cats
Anatomical therapeutic chemical veterinary (ATCvet) code
QP53BX03

Pharmacotherapeutic group

Other ectoparasiticides for systemic use

Therapeutic indication

Treatment and prevention of flea infestations (Ctenocephalides felis).

The preventive effect against re-infestations is a result of the adulticidal activity and the reduction in egg production and persists for up to 4 weeks after a single administration of the product.

The veterinary medicinal product can be used as part of a treatment strategy for the control of flea allergy dermatitis (FAD).

Authorisation details

EMA product number
EMEA/V/C/002233
Marketing authorisation holder
Elanco GmbH

Heinz-Lohmann-Str. 4
27472 Cuxhaven
Germany

Opinion adopted
08/12/2010
Marketing authorisation issued
11/02/2011
Revision
12

Assessment history

This page was last updated on

Share this page